|
RAC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.432370E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.423400E-04 |
| Normal-vs-Stage2 |
2.191800E-02 |
| Normal-vs-Stage3 |
1.079710E-02 |
| Normal-vs-Stage4 |
3.276200E-02 |
| Stage1-vs-Stage2 |
8.982200E-01 |
| Stage1-vs-Stage3 |
6.960800E-01 |
| Stage1-vs-Stage4 |
9.962800E-01 |
| Stage2-vs-Stage3 |
7.175000E-01 |
| Stage2-vs-Stage4 |
9.240800E-01 |
| Stage3-vs-Stage4 |
8.051200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.446260E-04 |
| Normal-vs-AfricanAmerican |
4.205900E-02 |
| Normal-vs-Asian |
1.538960E-03 |
| Caucasian-vs-AfricanAmerican |
8.494000E-01 |
| Caucasian-vs-Asian |
3.485600E-01 |
| AfricanAmerican-vs-Asian |
6.591800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.386300E-04 |
| Normal-vs-Female |
5.406800E-04 |
| Male-vs-Female |
4.023600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.028000E-04 |
| Normal-vs-Age(41-60Yrs) |
5.179600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.491180E-01 |
| Normal-vs-Age(81-100Yrs) |
5.006000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.734400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.148000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.640200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.770230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.543400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.849000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.367200E-01 |
| Classical-VS-Follicular |
1.14260000017019E-07 |
| Classical-VS-Other |
9.815700E-02 |
| Classical-VS-Normal |
5.64479999964895E-07 |
| Tall-VS-Follicular |
6.42479999999335E-05 |
| Tall-VS-Other |
2.314800E-01 |
| Tall-VS-Normal |
6.33439999999652E-05 |
| Follicular-VS-Other |
9.173000E-01 |
| Follicular-VS-Normal |
6.747800E-01 |
| Other-VS-Normal |
9.708400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.729810E-02 |
| Normal-vs-N1 |
1.563610E-01 |
| N0-vs-N1 |
9.902600E-01 |
|
|
